NeoCLEAR

NeoCLEAR: Neonatal Champagne Lumbar punctures Every time – An RCT is a multicentre, randomised controlled trial to investigate techniques to increase lumbar puncture success in newborn babies. Lumbar puncture is a procedure performed to diagnose meningitis or another neurological condition, and sometimes as treatment for certain neurological problems. The main aim of the NeoCLEAR trial is to understand if there is a best technique for achieving a successful lumbar puncture in newborn babies, ‘best’ being defined as the technique which produces the clearest sample of cerebrospinal fluid (CSF) in the fewest possible number of attempts.

Recruitment
Total
0281
Target
1020

The latest infant was recruited at Norfolk and Norwich University Hospital on 18 April 2019

If one of the four combinations of techniques is found to be more effective than others, the hope is that the results of this study will help inform the care of babies in the future.

Direct link to MP4

REC Reference:
18/SC/0222
ISRCTN:
14040914
Clinical Trials Unit:
National Perinatal Epidemiology Unit CTU
Sponsor:
University of Oxford
Funder:
NIHR Health Technology Assessment (HTA) Programme
Recruitment Target:
1,020
Duration of Study:
September 2017 - August 2020

NeoCLEAR News

See all news

This study is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (Reference Number 15/188/106). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.